title: Solution-state NMR spectroscopy of famotidine revisited: spectral assignment, protonation sites, and their structural consequences.
abstract: Multinuclear one (1D-) and two-dimensional (2D) nuclear magnetic resonance (NMR) spectroscopic investigations of famotidine, the most potent and widely used histamine H(2)-receptor antagonist, were carried out in dimethyl sulfoxide-d(6) (DMSO-d(6)) and water. Previous NMR assignments were either incomplete or full assignment was based only on 1D spectra and quantum-chemical calculations. Our work revealed several literature misassignments of the (1)H, (13)C, and (15)N NMR signals and clarified the acid-base properties of the compound at the site-specific level. The erroneous assignment of Baranska et al. (J. Mol. Struct. 2001, 563) probably originates from an incorrect hypothesis about the major conformation of famotidine in DMSO-d(6). A folded conformation similar to that observed in the solid-state was also assumed in solution, stabilized by an intramolecular hydrogen bond involving one of the sulphonamide NH(2) protons and the thiazole nitrogen. Our detailed 1D and 2D NMR experiments enabled complete ab initio (1)H, (13)C, and (15)N assignments and disproved the existence of the sulphonamide NH hydrogen bond in the major conformer. Rather, the molecule is predominantly present in an extended conformation in DMSO-d(6). The aqueous acid-base properties of famotidine were studied by 1D (1)H- and 2D (1)H/(13)C heteronuclear multiple-bond correlation (HMBC) NMR-pH titrations. The experiments identified its basic centers including a new protonation step at highly acidic conditions, which was also confirmed by titrations and quantum-chemical calculations on a model compound, 2-[4-(sulfanylmethyl)-1,3-thiazol-2-yl]guanidine. Famotidine is now proved to have four protonation steps in the following basicity order: the sulfonamidate anion protonates at pH = 11.3, followed by the protonation of the guanidine group at pH = 6.8, whereas, in strong acidic solutions, two overlapping protonation processes occur involving the amidine and thiazole moieties.
authors.affiliation: Department of Pharmaceutical Chemistry, Semmelweis University, 1092 Budapest, Hőgyes Endre u. 9, Hungary.
authors.forename: Attila
authors.initials: A
authors.lastname: Marosi
authors.forename: Zsófia
authors.initials: Z
authors.lastname: Szalay
authors.forename: Szabolcs
authors.initials: S
authors.lastname: Béni
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Szakács
authors.forename: Tamás
authors.initials: T
authors.lastname: Gáti
authors.forename: Ákos
authors.initials: Á
authors.lastname: Rácz
authors.forename: Béla
authors.initials: B
authors.lastname: Noszál
authors.forename: Ádám
authors.initials: Á
authors.lastname: Demeter
mesh_terms: D004121:Dimethyl Sulfoxide / Q000737:chemistry; D015738:Famotidine / Q000737:chemistry*; D006635:Histamine H2 Antagonists / Q000737:chemistry*; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D008958:Models, Molecular; D008968:Molecular Conformation; D011522:Protons; D014867:Water / Q000737:chemistry
chemical_list: D006635:Histamine H2 Antagonists; D011522:Protons; D014867:Water; D015738:Famotidine; D004121:Dimethyl Sulfoxide